PlainRecalls
FDA Drug Moderate Class II Terminated

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.

Reported: September 25, 2019 Initiated: August 23, 2019 #D-1868-2019

Product Description

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
Aurolife Pharma, LLC
Units Affected
a) 11,928 cartons; b) 288 cartons
Distribution
Nationwide in the USA
Location
Dayton, NJ

Frequently Asked Questions

What product was recalled?
Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.. Recalled by Aurolife Pharma, LLC. Units affected: a) 11,928 cartons; b) 288 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on September 25, 2019. Severity: Moderate. Recall number: D-1868-2019.